Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Goal Of Good Quality Medicines Advanced By New USP Agreement With 9 ASEAN Countries
Furthering its mission to improve the quality of medicines worldwide, the U.S. Pharmacopeial (USP) Convention has signed a cooperative agreement with nine countries belonging to the Association of Southeast Asian Nations (ASEAN). In a drive to strengthen capacities and certification status of national drug quality control laboratories, officials from Cambodia, Laos, Myanmar, Singapore, Vietnam, Indonesia, Malaysia, the Philippines and Thailand had formed an ASEAN Reference Materials Working Group (ARMWG) to focus on modern, international measurement standards for medicines in the region. The agreement with USP is the culmination of discussions that started in 2008 with the aim of improving the production, precision and quality of ASEAN Reference Substances (ARS).
generic viagra online
Minister Brady Announces Publication Of 2008 Annual Report Of The Alcohol Marketing Communications Monitoring Body, Ireland
Ms Aine Brady T.D. Minister for Older People and Health Promotion, announced the publication of the 2008 Annual Report from the Alcohol Marketing Communications Monitoring Body (AMCMB). The AMCMB was established to monitor the level of adherence by advertisers and media owners to the Codes of Practice on Alcohol Marketing, Communications and Sponsorship. The AMCMB has concluded that there continues to be overall compliance with the Codes.
News of the day
MAP Pharmaceuticals Phase 3 Trial Of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX(TM) orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
Health Insurance

MS Society Appoints New Director

The MS Society has appointed Sue Farrington to its newly created role of Director of Information and Education. Sue was formerly Director of Corporate Affairs at CSV. In her new role, which starts this month, Sue is responsible for the management of the MS Society"s information for people affected by MS - through its website, annual conference programme and publications team. Sue will also be overseeing a drive to improve the Society"s professional education programme. Speaking about her new role, Sue said: "As technologies converge, the MS Society has a great opportunity to respond to people"s information needs in the way that they want." Sue joins the charity with 14 years of senior management experience behind her. In her last role at CSV - the UK"s largest volunteering and training organisation - she was responsible for communications, broadcast and campaigns. Previous to that she was Director of Media at the company, providing communications support and media employment training. Between 2004 and 2008 Sue served on the Ofcom Advisory Committee for England. MS Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009